About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00333151

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

This trial is conducted in the United States of America (USA) and Canada. This trial is designed to show the effect of treatment with liraglutide when added to existing rosiglitazone and metformin com...

Lead sponsor: Novo Nordisk A/S•71 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Novo Nordisk A/S

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Type 2 diabetes
•Treated with oral anti-diabetic (OAD) drugs for at least 3 months
•Treated with one or more OAD and in moderate to poor glycemic control
•Body Mass Index (BMI) less than or equal to 45.0 kg/m2

Exclusion Criteria

•Treatment with insulin within the last three months prior to the trial except due to intercurrent illness, at the discretion of the Investigator
•Any serious medical condition
•Treatment with any drug that could interfere with glucose level

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

NCT07102043 · Cystic Fibrosis Related Diabetes

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 25, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment576

Start dateMay 2006

Last updatedJan 25, 2017

Condition

Diabetes Diabetes Mellitus, Type 2

Locations shown

Novo Nordisk Investigational Site

Goodyear, Arizona

Novo Nordisk Investigational Site

Colton, California

Novo Nordisk Investigational Site

Concord, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 25, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions